Loading…
Loading…
DSM-Firmenich AG is a Swiss/Dutch life-sciences and ingredients group formed in 2023 from the merger of Royal DSM (NL) and Firmenich (CH); the merged entity's registered legal seat is Kaiseraugst, Switzerland, with a co-headquarters in Maastricht, Netherlands, and its shares list on Euronext Amsterdam (DSFIR).
Every exposure is read as a buyer dependency; the top 2 are its binding chokepoints.
As a buyer, policy pressure across its consumed materials is coverage-limited.
Descriptive trend in official policy actions on this company’s materials — a policy-pressure trend, not a price or trading signal. No forward probability is implied. Direction is measured on actions we have discovered, and discovery lags events: where the recent window is too thin to support a calm reading, the row says coverage-limited instead of easing.
No actions in the register have named or swept this company in the last 24 months.